Evidence map›Paper›PMID 38885924›Full record

ArticleThe American journal of pathology2024

Bifidobacterium bifidum Strain BB1 Inhibits Tumor Necrosis Factor-α-Induced Increase in Intestinal Epithelial Tight Junction Permeability via Toll-Like Receptor-2/Toll-Like Receptor-6 Receptor Complex-Dependent Stimulation of Peroxisome Proliferator-Activated Receptor γ and Suppression of NF-κB p65.

Raz Abdulqadir, Rana Al-Sadi, Mohammad Haque, Yash Gupta, Manmeet Rawat, Thomas Y Ma

Abstract read
In one paragraph

Article in The American journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Bioscience of microbiota, food and health · 2026
    Article
  5. Article
  6. Probiotics and the intestinal tight junction barrier function.Frontiers in cell and developmental biology · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raz AbdulqadirDepartment of Medicine, Penn State College of Medicine, Hershey Medical Center, Hershey, Pennsylvania. Electronic address: rabdulqadir@pennstatehealth.psu.edu.
Rana Al-SadiDepartment of Medicine, Penn State College of Medicine, Hershey Medical Center, Hershey, Pennsylvania.
Mohammad HaqueDepartment of Medicine, Penn State College of Medicine, Hershey Medical Center, Hershey, Pennsylvania.
Yash GuptaDepartment of Medicine, Penn State College of Medicine, Hershey Medical Center, Hershey, Pennsylvania.
Manmeet RawatDepartment of Medicine, Penn State College of Medicine, Hershey Medical Center, Hershey, Pennsylvania.
Thomas Y MaDepartment of Medicine, Penn State College of Medicine, Hershey Medical Center, Hershey, Pennsylvania. Electronic address: thomasma@pennstatehealth.psu.edu.

Funding

TNF-alpha Regulation of Intestinal Paracellular TransportR01DK064165 · NIDDK · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MA, THOMAS Y · 2003 to 2018
$5.2M
Intestinal Barrier, Probiotic Bacteria, and the Gut-Liver AxisR01DK121073 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MA, THOMAS Y · 2019 to 2023
$2.4M
Bifidobacterium bifidum modulation of intestinal barrier and intestinal inflammation.R01DK106072 · NIDDK · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MA, THOMAS Y · 2016 to 2019
$1.8M
NIDDK NIH HHS R01 DK064165NIDDK NIH HHS R01 DK106072NIDDK NIH HHS R01 DK121073
6 · The paper itself

Abstract

Bifidobacterium bifidum strain BB1 causes a strain-specific enhancement in intestinal epithelial tight junction (TJ) barrier. Tumor necrosis factor (TNF)-α induces an increase in intestinal epithelial TJ permeability and promotes intestinal inflammation. The major purpose of this study was to delineate the protective effect of BB1 against the TNF-α-induced increase in intestinal TJ permeability and to unravel the intracellular mechanisms involved. TNF-α produces an increase in intestinal epithelial TJ permeability in Caco-2 monolayers and in mice. Herein, the addition of BB1 inhibited the TNF-α increase in Caco-2 intestinal TJ permeability and mouse intestinal permeability in a strain-specific manner. BB1 inhibited the TNF-α-induced increase in intestinal TJ permeability by interfering with TNF-α-induced enterocyte NF-κB p50/p65 and myosin light chain kinase (MLCK) gene activation. The BB1 protective effect against the TNF-α-induced increase in intestinal permeability was mediated by toll-like receptor-2/toll-like receptor-6 heterodimer complex activation of peroxisome proliferator-activated receptor γ (PPAR-γ) and PPAR-γ pathway inhibition of TNF-α-induced inhibitory kappa B kinase α (IKK-α) activation, which, in turn, resulted in a step-wise inhibition of NF-κB p50/p65, MLCK gene, MLCK kinase activity, and MLCK-induced opening of the TJ barrier. In conclusion, these studies unraveled novel intracellular mechanisms of BB1 protection against the TNF-α-induced increase in intestinal TJ permeability. The current data show that BB1 protects against the TNF-α-induced increase in intestinal epithelial TJ permeability via a PPAR-γ-dependent inhibition of NF-κB p50/p65 and MLCK gene activation.

Indexed as

Bifidobacterium bifidumIntestinal MucosaMyosin-Light-Chain KinasePermeabilityPPAR gammaTight JunctionsToll-Like Receptor 2Transcription Factor RelATumor Necrosis Factor-alphaAnimalsCaco-2 CellsHumansMiceMice, Inbred C57BLProbioticsToll-Like Receptor 6Myosin-Light-Chain KinasePPAR gammaToll-Like Receptor 2Toll-Like Receptor 6Transcription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID38885924
PMCPMC11372998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.